
|Articles|April 30, 2008
Cefixime tablets make return to market
Lupin Pharmaceuticals announces manufacture of cefixime 400-mg tablets.
Advertisement
 Since 2002, when 
 To see more Daily News articles, 
To go to the Drug Topics homepage, 
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How PBMs Legally Challenged Arkansas’ Pharmacy Ownership Law | NCPA 2025
2
COVID-19 Vaccination Benefits Patients With Systemic Lupus Erythematosus
3
General Awareness of PBM Practices Driving Optimism for Independent Pharmacies | NCPA 2025
4
FDA Releases Biosimilar Guidance Pushing to Streamline Development
5

























































































































































